Skip to main content
Daily Report

Daily Sepsis Research Analysis

03/07/2025
3 papers selected
3 analyzed

Three impactful sepsis-related studies span mechanistic science, diagnostics, and bedside management. Neonatal monocyte metabolism (oxidative phosphorylation vs. glycolysis) offers a mechanistic lens on early-life sepsis risk, ascitic MR-pro-ADM combined with PMN and Child-Pugh improves SBP diagnosis, and an RCT shows ultrasound-guided individualized fluid management benefits in septic shock.

Summary

Three impactful sepsis-related studies span mechanistic science, diagnostics, and bedside management. Neonatal monocyte metabolism (oxidative phosphorylation vs. glycolysis) offers a mechanistic lens on early-life sepsis risk, ascitic MR-pro-ADM combined with PMN and Child-Pugh improves SBP diagnosis, and an RCT shows ultrasound-guided individualized fluid management benefits in septic shock.

Research Themes

  • Neonatal immunometabolism and sepsis susceptibility
  • Biomarker-enhanced diagnosis of spontaneous bacterial peritonitis
  • Ultrasound-guided individualized fluid resuscitation in septic shock

Selected Articles

1. Oxidative phosphorylation is a key feature of neonatal monocyte immunometabolism promoting myeloid differentiation after birth.

8.15Level VCohort
Nature communications · 2025PMID: 40050264

Using multi-omic and functional analyses of healthy human monocytes across ages, the study shows neonatal monocytes rely on oxidative phosphorylation to support myeloid differentiation, with a developmental shift toward glycolysis that heightens inflammatory responsiveness. Microbial stimulation can induce adult-like metabolism in neonatal cells, while adult ketogenic diet does not recreate neonatal immunometabolism. Premature glycolytic activation may increase neonatal sepsis risk by impairing differentiation and promoting hyperinflammation.

Impact: This mechanistic work defines age-dependent immunometabolic programming in human monocytes with direct implications for neonatal sepsis susceptibility. It opens avenues for metabolic-targeted strategies and careful timing of interventions in early life.

Clinical Implications: While not yet practice-changing, the findings suggest caution against interventions that prematurely enhance glycolysis in neonates and motivate biomarker development for metabolic state to stratify sepsis risk in early life.

Key Findings

  • Neonatal monocytes exhibit enhanced oxidative phosphorylation supporting myeloid differentiation.
  • Developmental shift toward glycolysis in early childhood increases inflammatory responsiveness.
  • Microbial stimulation induces adult-like metabolism in neonatal monocytes; adult ketogenic diet does not recreate neonatal immunometabolism.
  • Premature glycolytic activation may increase neonatal sepsis risk by impairing differentiation and promoting hyperinflammation.

Methodological Strengths

  • Integrated transcriptomic, metabolic, and immunological analyses in human samples across ages
  • Functional perturbation with microbial stimulation to test metabolic plasticity

Limitations

  • Primarily ex vivo mechanistic evidence without direct clinical outcome linkage
  • Lack of interventional trials to test whether modulating metabolism alters sepsis incidence

Future Directions: Prospective neonatal cohorts linking immunometabolic states to infection outcomes, and ethically designed interventions to modulate metabolism for sepsis prevention.

Neonates primarily rely on innate immune defense, yet their inflammatory responses are usually restricted compared to adults. This is controversially interpreted as a sign of immaturity or essential programming, increasing or decreasing the risk of sepsis, respectively. Here, combined transcriptomic, metabolic, and immunological studies in monocytes of healthy individuals reveal an inverse ontogenetic shift in metabolic pathway activities with increasing age. Neonatal monocytes are characterized by enhanced oxidative phosphorylation supporting ongoing myeloid differentiation. This phenotype is gradually replaced during early childhood by increasing glycolytic activity fueling the inflammatory responsiveness. Microbial stimulation shifts neonatal monocytes to an adult-like metabolism, whereas ketogenic diet in adults mimicking neonatal ketosis cannot revive a neonate-like metabolism. Our findings disclose hallmarks of innate immunometabolism during healthy postnatal immune adaptation and suggest that premature activation of glycolysis in neonates might increase their risk of sepsis by impairing myeloid differentiation and promoting hyperinflammation.

2. Mid-regional pro-adrenomedullin: A rapid sepsis biomarker for diagnosing spontaneous bacterial peritonitis in cirrhosis.

6.6Level IIICohort
European journal of clinical investigation · 2025PMID: 40052388

Ascitic MR-pro-ADM was significantly elevated in bacteriologically confirmed SBP and showed moderate discrimination (AUROC 0.746) with an optimal cut-off of ≥2.5 nmol/L. A composite SBP score integrating MR-pro-ADM, PMN ≥250/mm³, and Child-Pugh class improved diagnostic performance compared to single markers.

Impact: Introduces a rapid, biologically plausible sepsis biomarker in ascites and a composite score that may streamline SBP diagnosis and early antibiotic decisions in cirrhosis.

Clinical Implications: Adding ascitic MR-pro-ADM (≥2.5 nmol/L) to PMN count and Child-Pugh can improve SBP triage; implementation could accelerate appropriate antibiotics while avoiding unnecessary treatment when scores are low.

Key Findings

  • Ascitic MR-pro-ADM levels are higher in bacteriologically confirmed SBP than in non-SBP (3.14 vs 1.91 nmol/L; p=0.0002).
  • Optimal MR-pro-ADM cut-off ≥2.5 nmol/L yields AUROC 0.746 (95% CI 0.685–0.801).
  • Procalcitonin in ascites showed poor discrimination, while a composite 'SBP score' (MR-pro-ADM, PMN ≥250/mm³, Child-Pugh) improved diagnostic accuracy.

Methodological Strengths

  • Derivation and independent validation cohorts with multivariable modeling
  • Use of Bayesian ANOVA and ROC analysis to quantify discriminative performance

Limitations

  • Exact sample sizes and external generalizability are not specified in the abstract
  • Cross-sectional design precludes evaluation of clinical impact on outcomes

Future Directions: Prospective, multicenter impact and cost-effectiveness studies of the SBP score, and development of rapid ascitic MR-pro-ADM assays for bedside use.

BACKGROUND: Spontaneous bacterial peritonitis (SBP) is a frequent and life-threatening complication of cirrhosis, contributing to considerable morbidity and mortality. METHODS: A cross-sectional derivation study was conducted to assess the diagnostic accuracy of two sepsis-related calcitonin peptide family biomarkers, mid-regional pro-adrenomedullin (MR-pro-ADM) and procalcitonin, in ascitic fluid for identifying bacteriologically confirmed SBP (BC-SBP). In a subsequent validation study, the diagnostic performance of the 'SBP score' was evaluated in an independent patient cohort using an absolute polymorphonuclear (PMN) leukocyte count threshold of ≥250 cells/mm RESULTS: In the derivation study, the concentration of MR-pro-ADM in ascitic fluid was significantly higher in patients with BC-SBP compared to those without BC-SBP (3.14 nmol/L [IQR, 2.39-6.74] vs. 1.91 nmol/L [IQR, 1.33-2.80]; p = .0002). Bayesian ANOVA indicated that MR-pro-ADM was highly discriminative for diagnosing BC-SBP, with a substantial Bayes factor (BFM = 2505), whereas procalcitonin exhibited poor discriminatory performance. Receiver-operating characteristic (ROC) analysis identified an optimal MR-pro-ADM cut-off of ≥2.50 nmol/L for diagnosing BC-SBP, with an area under the ROC curve (AUROC) of 0.746 (95% CI, 0.685-0.801; p < .0001). Multivariable logistic regression identified three independent predictors of BC-SBP, which were subsequently incorporated into the 'SBP score' (MR-pro-ADM ≥2.5 nmol/L, absolute PMN count ≥250 cells/mm CONCLUSION: MR-pro-ADM in ascitic fluid emerges as a promising biomarker for SBP diagnosis. Combining MR-pro-ADM with absolute PMN count and Child-Pugh score in the 'SBP score' greatly improves the diagnostic accuracy of SBP.

3. Ultrasound-Guided Fluid Volume Management in Patients With Septic Shock: A Randomized Controlled Trial.

6.55Level IRCT
Journal of trauma nursing : the official journal of the Society of Trauma Nurses · PMID: 40053551

In a single-center RCT (n=113), critical care ultrasound-guided fluid management in septic shock improved T6 lactate and lactate clearance and reduced pulmonary edema, left heart failure, SOFA scores, and ICU length of stay compared with guideline-based care alone.

Impact: Provides randomized evidence supporting individualized, ultrasound-guided resuscitation in septic shock with improvements in physiological surrogates and complications.

Clinical Implications: Integrating critical care ultrasound into early fluid resuscitation can individualize volume status assessment and potentially reduce over-resuscitation-related complications; multicenter trials should confirm effects on mortality.

Key Findings

  • Ultrasound-guided group had lower blood lactate and higher lactate clearance at 6 hours (P < .05).
  • Reduced pulmonary edema and left heart failure at T6 in the ultrasound group (P < .05).
  • Lower SOFA scores and shorter ICU length of stay in the ultrasound group (P < .05).

Methodological Strengths

  • Prospective randomized controlled design with standardized guideline-based care in both arms
  • Objective physiological and clinical endpoints assessed at predefined time points

Limitations

  • Single-center trial with modest sample size and short-term primary assessments (6-hour metrics)
  • Blinding not described; mortality and long-term outcomes not reported

Future Directions: Multicenter, adequately powered RCTs with protocolized ultrasound algorithms to assess effects on mortality, renal failure, and ventilator days.

BACKGROUND: Ultrasound-guided fluid management is increasingly used in the intensive care unit, yet it's benefits in septic shock remains unknown. OBJECTIVE: To evaluate the use of critical care ultrasound for individualized volume management in septic shock patients. METHODS: A single-center, randomized controlled, prospective study was conducted on patients with septic shock admitted to the intensive care unit in Xi'an Daxing Hospital, Xi'an City, China, from September 2022 to December 2023. Upon intensive care unit admission, the patients were resuscitated according to the latest sepsis and septic shock guidelines and early goal-directed therapy. The study group additionally underwent critical care ultrasound examination to monitor and guide the adjustment of fluid resuscitation in real-time. The two groups' physiological and biochemical indexes and prognoses were compared before (T0) and 6 hours after (T6) fluid resuscitation. RESULTS: A total of 113 patients with septic shock were selected and randomly allocated into study (n = 57) and control (n = 56) groups. The central venous oxygen saturation, heart rate, mean arterial pressure, blood lactate, and lactate clearance rate of the two groups at T6 were significantly improved compared to T0 (P < .05). At T6, the study group's blood lactate was significantly lower and the lactate clearance was significantly higher than the control group (P < .05). At T6, the incidence of pulmonary edema, incidence of left heart failure, Sequential Organ Failure Assessment (SOFA) score and length of the intensive care unit hospitalization in the study group were significantly lower than the control group (P < .05). CONCLUSION: The application of critical care ultrasound improved the outcome and helped guide individualized management of patients with septic shock.